Abstract Body

Background

Sex workers (SW) experience high HIV incidence, yet the potential benefit of daily oral pre-exposure prophylaxis (PrEP) is limited by poor continuation. Enabling pharmacy-based PrEP collection has potential to improve continuation among SW allowing anonymity, convenient location, long operating hours and shorter waiting times. We piloted pharmacy-based PrEP prescription refills to improve continuation; the Together Optimizing PrEP Access in Zimbabwe (TOPAZ) intervention.

Methods

TOPAZ was co-developed with SW and pharmacists and is embedded within Zimbabwe’s nationally scaled Key Populations (KP) program, which provides free HIV and sexual & reproductive health services to sex workers. Four randomly selected residential suburbs in Harare with at least 3 eligible pharmacies were allocated to TOPAZ and compared to one large KP program clinic (standard-of-care (SOC)). In the SOC site, SW ≥16 years initiating PrEP were advised to collect PrEP refills from any KP program clinic as usual. In TOPAZ suburbs, SW initiating PrEP had the option to collect refills from pharmacies or KP program clinics. To enhance habit formation, SW collecting refills at pharmacies were offered gift vouchers redeemable at the pharmacy, escalating in value, (US$5, US$6 and US$7 at months 1, 3 and 6, respectively). We present PrEP continuation at 1 and 3 months, defined as collecting prescription refills within a 14-day window at months 1 and 3. PrEP refill data were compared between TOPAZ and SOC arms over the same time period. We compared the proportion of participants continuing PrEP and risk difference (RD) computed using logistic regression models.

Results

Between March-May 2024, we recruited 100 and 96 female SW with mean ages 29.3 (SD=7.2) and 27.7 (SD=6.1) years in TOPAZ and the SOC clinic, respectively. In the TOPAZ arm, all refills were made through pharmacies. At month 1, 78/100 (78.0%) participants collected PrEP refills in TOPAZ arm vs. 35/96 (36%) in the SOC clinic, RD 0.42 (95% confidence interval (CI): 0.31-0.52); p<0.01). At month 3, 67/100 (67.0%) in TOPAZ arm completed refills, cv 18/96 (19%) in SOC clinic, RD 0.48; 95% CI:0.4, 0.57; p<0.01), Figure 1.

Conclusions

Pharmacy-based PrEP was acceptable to SW in Zimbabwe and was associated with improved PrEP continuation at 3 months, demonstrating the potential of pharmacy-based PrEP delivery. Further research is needed to differentiate the effect of pharmacy collection from escalating incentives and confirm adherence with biomarkers. 

Table or Figure